This website uses cookies to enhance the user experience.
I

IFE HOLDING AS928 041 522

Process industry
Limited company
Instituttveien 18 2007 KJELLER, Norge

IFE HOLDING AS

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Organization

Chairman of the board
Years since formation
4 years
since Dec 2, 2021
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
90,000
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Annual total result 2023
-33,809
NOK
Total equity 2023
78,109,024
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-

Others

NameRoleShares
K
KPMG AS
Auditor-
Last update: May 28, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
I
INSTITUTT FOR ENERGITEKNIKK
Ordinary shares
90,000
100 %

Shares owned by the IFE HOLDING AS

NameShare classNumber of sharesShare
I
IFE INVEST AS
Ordinary shares
43,125
100 %
A
AGILERA PHARMA AS
Ordinary shares
30,000
100 %
Last update: May 24, 2024

Group structure

Financials

in NOK

Summary

Year20232021
Total operating income
0
0
Annual Total Result
-33,809
-1,200
Total assets
78,119,910
83,230
Total liabilities
10,886
0
Total equity
78,109,024
83,230

P&L

Year20232021
Total operating income
0
0
Total operating costs
33,809
1,200
Operating result
-33,809
-1,200
Financial income/costs
0
0
Profit before tax
-33,809
-1,200
Total tax & extraordinary income/cost
0
0
Annual Total Result
-33,809
-1,200

Balance overview

Year20232021
Total fixed assets
78,089,603
30,000
Total current assets
30,307
53,230
Total assets
78,119,910
83,230
Short term debt
10,886
0
Long term debt
0
0
Total liabilities
10,886
0
Contributed capital
78,144,033
84,430
Retained earnings
-35,009
-1,200
Total equity
78,109,024
83,230
Total equity and liabilities
78,119,910
83,230

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations